Digital pathology refers to the application of computers and networks to the field of pathology, a technology that organically combines modern digital systems with traditional optical magnification devices. It is a high-resolution digital image obtained by scanning and acquisition by a full-automatic microscope or optical magnification system. Then using a computer to automatically perform high-precision multi-field seamless stitching and processing of the captured image to obtain high-quality visualization data for use in various areas of pathology. The digital pathology system is mainly composed of a digital slice scanning device and data processing software.
Global Digital Pathology Market likely to grow with a substantial rate during the forecast period, 2020-2027. The rise in the adoption of digital pathology to enhance lab efficiency and the surge in the prevalence of cancer estimated to boom the global digital pathology market in the future time. Additionally, the swelling geriatric population that is susceptible to chronic conditions projected to fuel the growth of the global digital pathology industry. Digital pathology system can digitize and network pathological resources, and it realizes the permanent storage of visual data and the synchronous browsing processing without time and space restrictions. It is widely used in various fields of pathology.
Moreover, the increasing demand for digital pathology in disease diagnosis for improvising the safety, quality, and efficiency of disease diagnoses in pathology laboratories would trigger the digital pathology market size in the estimated period. The global digital pathology is driven by the increasing adoption of telepathology and the mounting healthcare investment in developed countries. The advent of digital pathology enables doctors to use digital technology to capture, stitch, compress, and store pathological images, retain high-quality image information, and combine with database technology to form digital pathological slicing systems. Furthermore, rapid technological advancements in digital pathology systems, coupled with the recently emerged new epidemic COVID-19 virus, will contribute to the augmentation of the digital pathology industry in the next few years.
With the rising incidence and mortality of cancers, pathology departments are facing considerable challenges in meeting the clinical needs for fast, accurate, targeted, and predictive pathological diagnosis. The emergence of AI-based pathology solved this problem. It can automatically analyze, segment, detect areas of interest, and quantitatively assess the degree of variation in diseased areas, thereby helping doctors share many repetitive, mechanical tasks, and improve work efficiency.
Digital pathological diagnosis can greatly reduce the workload of pathologists and help pathologists make an accurate diagnosis. At the same time, it saves the labor and time costs of the pathology department of the hospital and improves the quality and efficiency of pathological diagnosis. In underdeveloped areas, the diagnostic level of doctors in primary medical institutions has been improved, and the uneven distribution of medical resources for pathological diagnosis is resolved.
Based on the product, the global Digital Pathology market classified into Scanner, Software, Communications Systems, Storage Systems, and Others. The Scanner segment predicted to gain major market share in the market by 2027, due to the digital pathology help in analyzing multitudes of images with ease and aid in studying complex morphologies and features.
The Communications Systems segment will drive by advancement in cloud-based communication systems.
Based on type, the global digital pathology market bifurcated into Human Pathology and Veterinary Pathology. The Human Pathology segment projected to dominate the market by 2027 on account of the increasing demand for digital pathology to capture imaging, including CT and MRI, and helpful in making diagnosis faster.
The veterinary pathology segment will influence by its application in finding a diagnosis and capture images and scanning readily.
Based on application, the global Digital Pathology market classified into Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education, and Others. The Disease Diagnosis segment estimated to register a high CAGR by 2027, owing to the growing prevalence of chronic diseases, and it helps in improving each step in diagnostic and easy to share information within inter or intra departments.
Drug Discovery will boost by growing demand for numerous preclinical and clinical studies.
Based on end-user, the global Digital Pathology market categorized into Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Labs, and Academic & Research Institutes. Hospitals segment expected to gain maximum revenue by 2027 owing to the huge demand for Digital Pathology in hospitals for faster diagnosis and better patient compliance.
The Pharmaceutical & Biotechnology Companies segment will drive by its application for drug discovery studies and drug toxicology testing.
Based on geography, the global Digital Pathology market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to government support in the development of technologically advanced systems in the healthcare system and the presence of major players.
The Asia Pacific will drive by the surge in the growing penetration of digital imaging in developing countries, China and India, coupled with investments in the medical field.
Companies such as Omynx LLC, 3DHistech, Inc., Definiens, Olympus Corporation, GE Healthcare, Leica Biosystems, Philips Healthcare, Ventana Medical Systems, Inc., Objective Pathology Services; Hamamatsu Photonics, Inc., LigoLAb LLC and MicroSkan Technologies are the key players in the Global Digital Pathology Market.